Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Native mass spectrometry-based metabolomics identifies metal-binding compounds.
Nat Chem. 2022 Jan;14(1):100-109. doi: 10.1038/s41557-021-00803-1. Epub 2021 Nov 18.
Nat Chem. 2022.
PMID: 34795435
Free PMC article.
[Report from the Committee for Advanced Therapies (CAT). Pitfalls on the way from concept to medical treatment with advanced therapy medicinal products].
Reiss M, Büttel IC, Schneider CK.
Reiss M, et al. Among authors: buttel ic.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2011 Jul;54(7):822-30. doi: 10.1007/s00103-011-1304-3.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2011.
PMID: 21698535
Review.
German.
Item in Clipboard
Taking immunogenicity assessment of therapeutic proteins to the next level.
Büttel IC, Chamberlain P, Chowers Y, Ehmann F, Greinacher A, Jefferis R, Kramer D, Kropshofer H, Lloyd P, Lubiniecki A, Krause R, Mire-Sluis A, Platts-Mills T, Ragheb JA, Reipert BM, Schellekens H, Seitz R, Stas P, Subramanyam M, Thorpe R, Trouvin JH, Weise M, Windisch J, Schneider CK.
Büttel IC, et al.
Biologicals. 2011 Mar;39(2):100-9. doi: 10.1016/j.biologicals.2011.01.006. Epub 2011 Feb 24.
Biologicals. 2011.
PMID: 21353596
Item in Clipboard
Immunogenicity and its impact on benefit/risk considerations in the authorisation of biopharmaceuticals.
Büttel I, Völler K, Schneider C; European Medicines Agency.
Büttel I, et al.
Curr Drug Saf. 2010 Oct;5(4):287-92. doi: 10.2174/157488610792245993.
Curr Drug Saf. 2010.
PMID: 20615175
Item in Clipboard
Challenges with advanced therapy medicinal products and how to meet them.
Committee for Advanced Therapies (CAT); CAT Scientific Secretariat; Schneider CK, Salmikangas P, Jilma B, Flamion B, Todorova LR, Paphitou A, Haunerova I, Maimets T, Trouvin JH, Flory E, Tsiftsoglou A, Sarkadi B, Gudmundsson K, O'Donovan M, Migliaccio G, Ancāns J, Maciulaitis R, Robert JL, Samuel A, Ovelgönne JH, Hystad M, Fal AM, Lima BS, Moraru AS, Turcáni P, Zorec R, Ruiz S, Akerblom L, Narayanan G, Kent A, Bignami F, Dickson JG, Niederwieser D, Figuerola-Santos MA, Reischl IG, Beuneu C, Georgiev R, Vassiliou M, Pychova A, Clausen M, Methuen T, Lucas S, Schüssler-Lenz M, Kokkas V, Buzás Z, MacAleenan N, Galli MC, Linē A, Gulbinovic J, Berchem G, Fraczek M, Menezes-Ferreira M, Vilceanu N, Hrubisko M, Marinko P, Timón M, Cheng W, Crosbie GA, Meade N, di Paola ML, VandenDriessche T, Ljungman P, D'Apote L, Oliver-Diaz O, Büttel I, Celis P.
Committee for Advanced Therapies (CAT), et al. Among authors: buttel i.
Nat Rev Drug Discov. 2010 Mar;9(3):195-201. doi: 10.1038/nrd3052.
Nat Rev Drug Discov. 2010.
PMID: 20190786
Review.
Item in Clipboard
Common fragile sites and cancer: targeted cloning by insertional mutagenesis.
Büttel I, Fechter A, Schwab M.
Büttel I, et al.
Ann N Y Acad Sci. 2004 Dec;1028:14-27. doi: 10.1196/annals.1322.002.
Ann N Y Acad Sci. 2004.
PMID: 15650228
Review.
Item in Clipboard
Cite
Cite